Connect with us

Business

Johnson & Johnson gears up for collaboration on COVID vaccine supply – Sydney Morning Herald

The pharmaceutical giant is progressing development of its COVID vaccine, potentially giving Australia another option to import.

Published

on

Pharmaceutical giant Johnson & Johnson is rapidly scaling up its manufacturing capabilities as it progresses development of its COVID vaccine and says it will be looking to work with governments to discuss fast-tracking supply if successful.
The vaccine hopeful is yet another option Australia will most likely have to negotiate to import if it wants supply, with the $US390 billion ($544 billion) biotech firm looking to the US and Europe for trials and broader manufacturing.
From AstraZeneca…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending